Search
Atopic Dermatitis Clinical Trials in Lancaster, CA
A listing of 4 Atopic Dermatitis clinical trials in Lancaster, CA actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 4 of 4
The city of Lancaster, California, currently has 4 active clinical trials seeking participants for Atopic Dermatitis research studies.
Featured Trial
Healthy Participants Needed (Colonoscopy + Cancer Screening)
Recruiting
Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
Conditions:
Healthy
Healthy Volunteers
Healthy Subjects
Healthy Volunteer
Healthy Participants
Featured Trial
COVID-19 Vaccine Clinical Trial (Compensation Provided)
Recruiting
Healthy adults ages 50-64 may qualify. You may be eligible if you haven’t received a COVID-19 vaccine and haven’t had COVID-19 in the last 90 days.
Qualified participants may receive compensation for time and travel.
Qualified participants may receive compensation for time and travel.
Conditions:
Healthy
Vaccine
COVID19
COVID-19
COVID-19 Vaccine
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Conditions:
Healthy
Healthy Volunteer Study
Featured Trial
Vaccine (65+) Clinical Study
Recruiting
We are seeking healthy participants aged 65 and above who are interested in participating in a vaccine clinical trial.
Conditions:
Vaccine (65+)
Healthy
Older Adults
Seniors
Healthy Volunteers
Featured Trial
Adult Vaccine Clinical Trial
Recruiting
Looking to boost your immunity?
You may be interested in participating in an Adult Vaccine Clinical Trial.
The Adult Vaccine Research Studies are looking for adults to evaluate the effectiveness of a potential vaccine.
You may be interested in participating in an Adult Vaccine Clinical Trial.
The Adult Vaccine Research Studies are looking for adults to evaluate the effectiveness of a potential vaccine.
Conditions:
Healthy
Healthy Volunteers
Healthy Subjects
Healthy Volunteer
Healthy Participants
Featured Trial
Vaccine (18+) Clinical Study
Recruiting
We are seeking healthy individuals aged 18 and above who are interested in participating in a vaccine clinical trial.
Conditions:
Vaccine (18+)
Healthy
Healthy Individuals
Healthy Volunteers
Healthy Subjects
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Recruiting
The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18 years of age with moderate-to-severe atopic dermatitis (AD).
Gender:
ALL
Ages:
Between 6 months and 17 years
Trial Updated:
08/21/2025
Locations: Antelope Valley Clinical Trials, Lancaster, California
Conditions: Atopic Dermatitis, Eczema
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Recruiting
The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.
Gender:
ALL
Ages:
Between 18 years and 74 years
Trial Updated:
08/14/2025
Locations: Antelope Valley Clinical Trials, Lancaster, California
A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
Recruiting
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Gender:
ALL
Ages:
Between 12 years and 100 years
Trial Updated:
08/13/2025
Locations: Antelope Valley Clinical Trials, Lancaster, California +1 locations
Conditions: Atopic Dermatitis
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
Recruiting
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
07/29/2025
Locations: Antelope Valley Clinical Trials, Lancaster, California
Conditions: Atopic Dermatitis (AD)
1 - 4 of 4
